Frederick S Buckner MD
Associate Professor, Medicine, University of Washington School of Medicine
Join to View Full Profile
PO Box# 1959Seattle, WA 98195
Phone+1 206-598-7600
Fax+1 206-598-6963
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Frederick Buckner, MD is an infectious disease specialist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Minnesota. He is affiliated with UW Medicine/University of Washington Medical Center, UW Medicine/Harborview Medical Center, and VA Puget Sound Healthcare System - Seattle.
Education & Training
University of Washington School of MedicineClass of 1988
Certifications & Licensure
WA State Medical License 1992 - 2027
MN State Medical License 1991 - 1993
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- activity of MRS-2541, a novel MetRS inhibitor, against a selection of resistant gram-positive organisms associated with serious hospital infections.John Domagala, Seyedhameneh Jahanbakhsh, Angela K Mendez, Chris M Pillar, Andrea Marra
Microbiology Spectrum. 2026-03-11 - 3 citationsA novel methionyl-tRNA synthetase inhibitor targeting gram-positive bacterial pathogens.Nora M R Molasky, Zhongsheng Zhang, J Robert Gillespie, John Domagala, Dawn Reyna
Antimicrobial Agents and Chemotherapy. 2024-12-05 - 1 citationsDescriptive and molecular epidemiology of leishmaniasis diagnosed from clinical samples in the United States, 2021-2022.Thao T Truong, Karissa Crawford, Ichih Wang-McGuire, Kendal Jensen, Aisha Mushtaq
Microbiology Spectrum. 2024-10-03
Press Mentions
IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA DesignationNovember 16th, 2021
Grant Support
- Drug Discovery for Chagas DiseaseUNIVERSITY OF WASHINGTON2019–2026
- Developing methionyl tRNA synthetase inhibitors as therapeutics for Chagas diseaseUNIVERSITY OF WASHINGTON2020–2025
- Structure-Based Optimization Of T. Brucei Methionyl Trna Synthetase InhibitorsNational Institute Of Allergy And Infectious Diseases2012
- Rational Development Of Anti-Trypanosoma Cruzi DrugsNational Institute Of Allergy And Infectious Diseases2006–2012
- Biochemistry Of Protein PrenylationNational Institute Of Allergy And Infectious Diseases2008–2011
